Skip to content

Opening book details…

Can I read Dabigatran versus Warfarin in Patients with Atrial Fibrillation on EtoBox?

Dabigatran versus Warfarin in Patients with Atrial Fibrillation by Stuart J. Connolly; Michael D. Ezekowitz; Salim Yusuf; John Eikelboom; Jonas Oldgren; Amit Parekh; Janice Pogue; Paul A. Reilly; Ellison Themeles; Jeanne Varrone; Susan Wang; Marco Alings; Denis Xavier; Jun Zhu; Rafael Diaz; Basil S. Lewis; Harald Darius; Hans-Christoph Diener; Campbell D. Joyner; Lars Wallentin is a Medicine article available to read on EtoBox.

What is Dabigatran versus Warfarin in Patients with Atrial Fibrillation about?

## Background: Warfarin reduces the risk of stroke in patients with atrial fibrillation but increases the risk of hemorrhage and is difficult to use. dabigatran is a new oral direct thrombin inhibitor. ## Methods: In this noninferiority trial, we randomly assigned 18,113 patients who had atrial fibrillation and a risk of stroke to receive, in a blinded fashion, fixed doses of dabigatran--110 mg or 150 mg twice daily--or, in an unblinded fashion, adjusted-dose warfarin. the median duration of the follow-up period was 2.0 years. the primary outcome was stroke or systemic embolism. ## Results: Rates of the primary outcome were 1.69% per year in the warfarin group, as compared with 1.53% per year in the group that received 110 mg of dabigatran (relative risk with dabigatran, 0.91; 95% confidence interval [ci], 0.74 to 1.11; p<0.001 for noninferiority) and 1.11% per year in the group that received 150 mg of dabigatran (relative risk, 0.66; 95% ci, 0.53 to 0.82; p<0.001 for superiority). the rate of major bleeding was 3.36% per year in the warfarin group, as compared with 2.71% per year in the group receiving 110 mg of dabigatran (p=0.003) and 3.11% per year in the group receiving 150 mg

Who reads Dabigatran versus Warfarin in Patients with Atrial Fibrillation?

It is typically read by researchers, students, and practitioners in Medicine.

Author
Stuart J. Connolly; Michael D. Ezekowitz; Salim Yusuf; John Eikelboom; Jonas Oldgren; Amit Parekh; Janice Pogue; Paul A. Reilly; Ellison Themeles; Jeanne Varrone; Susan Wang; Marco Alings; Denis Xavier; Jun Zhu; Rafael Diaz; Basil S. Lewis; Harald Darius; Hans-Christoph Diener; Campbell D. Joyner; Lars Wallentin
Publisher
Massachusetts Medical Society
Published
2009
Language
EN
Field
Medicine (Health Sciences)

More by Stuart J. Connolly; Michael D. Ezekowitz; Salim Yusuf; John Eikelboom; Jonas Oldgren; Amit Parekh; Janice Pogue; Paul A. Reilly; Ellison Themeles; Jeanne Varrone; Susan Wang; Marco Alings; Denis Xavier; Jun Zhu; Rafael Diaz; Basil S. Lewis; Harald Darius; Hans-Christoph Diener; Campbell D. Joyner; Lars Wallentin

Browse all works by Stuart J. Connolly; Michael D. Ezekowitz; Salim Yusuf; John Eikelboom; Jonas Oldgren; Amit Parekh; Janice Pogue; Paul A. Reilly; Ellison Themeles; Jeanne Varrone; Susan Wang; Marco Alings; Denis Xavier; Jun Zhu; Rafael Diaz; Basil S. Lewis; Harald Darius; Hans-Christoph Diener; Campbell D. Joyner; Lars Wallentin